Infinity Pharmaceuticals Profile

USD 0.04  1.82%

Infinity Pharmaceuticals exotic insider transaction detected

Infinity Pharmaceuticals Inc insider trading alert for general transaction of common stock by Tasker Seth A, General Counsel, on February 3, 2018. This event was filed by Infinity Pharmaceuticals with SEC on 2016-07-29. Initial filing of beneficial ownership - SEC Form 3 [view details]   

Infinity Pharmaceuticals Summary

Infinity Pharmaceuticals (INFI) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 22 people. Infinity Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 115.87 M. Infinity Pharmaceuticals conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 51.96 M outstanding shares of which 1.98 M shares are currently shorted by private and institutional investors with about 1.06 trading days to cover. INFINITY PHARMACE currently holds about 57.61 M in cash with (36.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.11.
Check Infinity Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 56.39%30 days 2.24  about 43.48%
Based on normal probability distribution, the odds of Infinity Pharmaceuticals to move above current price in 30 days from now is about 43.48% (This Infinity Pharmaceuticals probability density function shows the probability of Infinity Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Acadian Asset Management LlcCommon Shares190.6 K400 K
Steward Partners Investment Advisory LlcCommon Shares2.6 K5 K
View Infinity Pharmaceuticals Diagnostics

Selected Infinity Pharmaceuticals Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Infinity Pharmaceuticals Against Markets

Current Ratings

Infinity Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 6% 
Equity ratings for Infinity Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for patients with difficult-to-treat diseases in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 22 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameInfinity Pharmaceuticals
ChairmanAdelene PerkinsView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address784 Memorial Drive
CIK Number01113148.0
IndustryPharmaceutical Products
Contact Number617 453 1000
CurrencyUSD - US Dollar


Infinity Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
Infinity Pharmaceuticals current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Infinity Pharmaceuticals Analyst Advice  


Infinity Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.56February 28, 2017
Infinity Pharmaceuticals normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Infinity Pharmaceuticals Corporate Directors
Jeffrey Berkowitz Independent Director
Norman Selby Lead Outside Independent Director, MBA
Jose Baselga Independent Director, Ph.D
Please also check Risk vs Return Analysis. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.